Breaking News

Catalent Biologics Expands Capabilities

New investments have been made in response to increased industry demand

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions has unveiled plans for a multi-site expansion of its analytical and process development capabilities for biologics. These investments include an expansion of bioassay and protein characterization capabilities at its Kansas City, MO, facility, and additional integrated analytical capabilities at its Madison, WI, bio-manufacturing facility. Catalent provids standalone analytical services for large molecule products, with over 20 years of experience, and specific expert...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters